{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:36:54Z","timestamp":1783723014194,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11274-021-03016-3","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T20:38:33Z","timestamp":1613767113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Repositioning of antidepressant drugs and synergistic effect with ciprofloxacin against multidrug-resistant bacteria"],"prefix":"10.1007","volume":"37","author":[{"given":"Vit\u00f3ria S.","family":"Foletto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taci\u00e9li F.","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa B.","family":"Serafin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelita","family":"Bottega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00edsa N.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno R.","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5513-4853","authenticated-orcid":false,"given":"Rosmari","family":"H\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"issue":"7","key":"3016_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/cancers8070066","volume":"8","author":"K Ahmed","year":"2016","unstructured":"Ahmed K, Shaw HV, Koval A, Katanaev VL (2016) A second WNT for old drugs: drug repositioning against WNT-dependent cancers. Cancers 8(7):66","journal-title":"Cancers"},{"issue":"4","key":"3016_CR2","first-page":"409","volume":"24","author":"L Amaral","year":"2010","unstructured":"Amaral L, Martins A, Molnar J, Kristiansen JE, Martins M, Viveiros M et al (2010) Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB. In Vivo 24(4):409\u2013424","journal-title":"In Vivo"},{"key":"3016_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3:673\u2013683","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"3016_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4155\/fmc-2019-0307","volume":"12","author":"N Berdigaliyev","year":"2020","unstructured":"Berdigaliyev N, Aljofan M (2020) An overview of drug discovery and development. Future Med Chem 12(10):939\u2013947","journal-title":"Future Med Chem"},{"issue":"12","key":"3016_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nrd4675","volume":"14","author":"D Brown","year":"2015","unstructured":"Brown D (2015) Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void? Nat Rev Drug Discov 14(12):821\u2013832","journal-title":"Nat Rev Drug Discov"},{"key":"3016_CR6","unstructured":"Centers for Disease Control and Prevention (2017) Antibiotic use in the United States: progress and opportunities, Atlanta. https:\/\/www.cdc.gov\/antibiotic-use\/stewardship-report\/pdf\/stewardship-report.pdf"},{"key":"3016_CR7","unstructured":"Clinical and Laboratory Standards Institute (2012) M07-A9 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 9th edn. Wayne: CLSI document. ISBN: 1-56238-785-5. https:\/\/clsi.org\/media\/1632\/m07a10_sample.pdf"},{"issue":"6","key":"3016_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.arabjc.2015.08.008","volume":"10","author":"B Das","year":"2017","unstructured":"Das B, Dash SK, Mandal D, Ghosh T, Chattopadhyay S, Tripathy S et al (2017) Green synthesized silver nanoparticles destroy multidrug resistant bacteria via reactive oxygen species mediated membrane damage. Arab J Chem 10(6):862\u2013876","journal-title":"Arab J Chem"},{"key":"3016_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.micpath.2018.07.040","volume":"123","author":"AK De Sousa","year":"2018","unstructured":"De Sousa AK, Rocha JE, de Souza TG, de Freitas TS, Ribeiro-Filho J, Coutinho HDM (2018) New roles of fluoxetine in pharmacology: antibacterial effect and modulation of antibiotic activity. Microb Pathog 123:368\u2013371","journal-title":"Microb Pathog"},{"issue":"5","key":"3016_CR11","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1097\/MJT.0000000000001011","volume":"27","author":"VS Foletto","year":"2019","unstructured":"Foletto VS, Serafin MB, da Rosa TF, Bottega A, Coelho SS, Machado CS et al (2019) Fluoxetine and paroxetine: repositioning as a therapeutic alternative in the treatment of various diseases. Am J Ther 27(5):e547\u2013e551","journal-title":"Am J Ther"},{"key":"3016_CR12","doi-asserted-by":"publisher","first-page":"113894","DOI":"10.1016\/j.bcp.2020.113894","volume":"177","author":"P Gelosa","year":"2020","unstructured":"Gelosa P, Castiglioni L, Camera M, Sironi L (2020) Drug repurposing in cardiovascular diseases: opportunity or hopeless dream? Biochem Pharmacol 177:113894","journal-title":"Biochem Pharmacol"},{"key":"3016_CR13","doi-asserted-by":"publisher","first-page":"01","DOI":"10.20510\/ukjpb\/6\/i1\/173522","volume":"6","author":"M Hadera","year":"2018","unstructured":"Hadera M, Mehari S, Basha NS, Amha ND, Berhane Y (2018) Study on antimicrobial potential of selected non-antibiotics and its interaction with conventional antibiotics. UK J Pharm Biosci 6:01\u201307","journal-title":"UK J Pharm Biosci"},{"issue":"4","key":"3016_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3233\/JAD-200049","volume":"74","author":"M Ihara","year":"2020","unstructured":"Ihara M, Saito S (2020) Drug repositioning for Alzheimer\u2019s disease: finding hidden clues in old drugs. J Alzheimers Dis 74(4):1013\u20131028","journal-title":"J Alzheimers Dis"},{"key":"3016_CR15","first-page":"4","volume":"4","author":"I Kaur","year":"2016","unstructured":"Kaur I (2016) Novel strategies to combat antimicrobial resistance. J Infect Dis Ther 4:4","journal-title":"J Infect Dis Ther"},{"key":"3016_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-0711-11-18","volume":"11","author":"K Konat\u00e9","year":"2012","unstructured":"Konat\u00e9 K, Mavoungou JF, Lepengu\u00e9 AN, Aworet-Samveny RR, Hilou A, Souza A et al (2012) Antibacterial activity against \u03b2-lactamase producing Methicillin and Ampicillin-resistants Staphylococcus aureus: fractional Inhibitory Concentration Index (FICI) determination. Ann Clin Microbiol Antimicrob 11:18","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"28","key":"3016_CR17","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.2174\/0929867325666180706101404","volume":"26","author":"AK Konreddy","year":"2019","unstructured":"Konreddy AK, Rani GU, Lee K, Choi Y (2019) Recent drug-repurposing-driven advances in the discovery of novel antibiotics. Curr Med Chem 26(28):5363\u20135388","journal-title":"Curr Med Chem"},{"key":"3016_CR18","first-page":"365","volume-title":"Antibiotics in laboratory medicine","author":"V Lorian","year":"2005","unstructured":"Lorian V (2005) Antibiotics in laboratory medicine, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 365\u2013441","edition":"5"},{"issue":"1","key":"3016_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/jps.1167","volume":"91","author":"B Meibohm","year":"2002","unstructured":"Meibohm B, Derendorf H (2002) Pharmacokinetic\/pharmacodynamic studies in drug product development. J Pharm Sci 91(1):18\u201331","journal-title":"J Pharm Sci"},{"key":"3016_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fpubh.2014.00145","volume":"2","author":"CA Michael","year":"2014","unstructured":"Michael CA, Dominey-Howes D, Labbate M (2014) The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health 2:145","journal-title":"Front Public Health"},{"issue":"10","key":"3016_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fmicb.2019.00041","volume":"28","author":"A Mir\u00f3-Canturri","year":"2019","unstructured":"Mir\u00f3-Canturri A, Ayerbe-Algaba R, Smani Y (2019) Drug repurposing for the treatment of bacterial and fungal infections. Front Microbiol 28(10):41","journal-title":"Front Microbiol"},{"issue":"3","key":"3016_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.pop.2018.05.006","volume":"45","author":"MS Morehead","year":"2018","unstructured":"Morehead MS, Scarbrough C (2018) Emergence of global antibiotic resistance. Prim Care Clin Office Pract 45(3):467\u2013484","journal-title":"Prim Care Clin Office Pract"},{"issue":"3","key":"3016_CR23","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1111\/j.1469-0691.2011.03752.x","volume":"18","author":"JW Mouton","year":"2011","unstructured":"Mouton JW, Brown DFJ, Apfalter P, Cant\u00f3n R, Giske CG, Ivanova M et al (2011) The role of pharmacokinetics\/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin Microbiol Infect 18(3):E37-45","journal-title":"Clin Microbiol Infect"},{"key":"3016_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR (2019) Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol 10:539","journal-title":"Front Microbiol"},{"issue":"3","key":"3016_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0924-8579(99)00154-5","volume":"14","author":"JL Munoz-Bellido","year":"2000","unstructured":"Munoz-Bellido JL, Munoz-Criado S, Garc\u00eca-Rodr\u00ecguez J\u00c1 (2000) Antimicrobial activity of psychotropic drugs selective serotonin reuptake inhibitors. Int J Antimicrob Agents 14(3):177\u2013180","journal-title":"Int J Antimicrob Agents"},{"key":"3016_CR26","unstructured":"National Committee for Clinical Laboratory Standards (1999) Methods for determining bactericidal activity of antimicrobial agents: approved guideline M26-A. vol. 19; No. 8. NCCLS, Wayne. https:\/\/clsi.org\/media\/1462\/m26a_sample.pdf"},{"key":"3016_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.micpath.2018.11.056","volume":"127","author":"JBA Neto","year":"2019","unstructured":"Neto JBA, Josino MAA, da Silva CR, Campos RS, Nascimento FBSA, Sampaio LS et al (2019) A mechanistic approach to the in-vitro resistance modulating effects of fluoxetine against meticillin resistant Staphylococcus aureus strains. Microb Pathog 127:335\u2013340","journal-title":"Microb Pathog"},{"issue":"1","key":"3016_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemoth 52(1):1","journal-title":"J Antimicrob Chemoth"},{"issue":"1","key":"3016_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijantimicag.2018.09.003","volume":"53","author":"RG Otto","year":"2019","unstructured":"Otto RG, van Gorp E, Kloezen W, Meletiadis J, van den Berg S, Mouton JW (2019) An alternative strategy for combination therapy: Interactions between polymyxin B and non-antibiotics. Int J Antimicrob Agents 53(1):34\u201339","journal-title":"Int J Antimicrob Agents"},{"key":"3016_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","volume":"9","author":"SM Paul","year":"2010","unstructured":"Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR et al (2010) How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge. Nat Rev Drug Discov 9:203\u2013214","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3016_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18(1):41\u201358","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"3016_CR32","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/molecules25051154","volume":"25","author":"G Rastelli","year":"2020","unstructured":"Rastelli G, Pellati F, Pinzi L, Gamberini MC (2020) Repositioning natural products in drug discovery. Molecules 25(5):1154","journal-title":"Molecules"},{"key":"3016_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nmni.2015.02.007","volume":"6","author":"I Roca","year":"2015","unstructured":"Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S et al (2015) The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect 6:22\u201329","journal-title":"New Microbes New Infect"},{"key":"3016_CR34","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.26694\/repis.v4i0.7350","volume":"4","author":"TS Rodrigues","year":"2018","unstructured":"Rodrigues TS, dos Santos AMR, Lima PC, Moura MEB, Goiano PDOL, Fontinele DRS (2018) Resist\u00eancia bacteriana \u00e1 antibi\u00f3ticos na Unidade de Terapia Intensiva: Revis\u00e3o Integrativa. Rev Pre Infec e Sa\u00fade 4:7350","journal-title":"Rev Pre Infec e Sa\u00fade"},{"key":"3016_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bjid.2018.05.007","volume":"22","author":"MB Serafin","year":"2018","unstructured":"Serafin MB, H\u00f6rner R (2018) Drug repositioning, a new alternative in infectious diseases. Braz J Infect Dis 22:252\u2013256","journal-title":"Braz J Infect Dis"},{"issue":"12","key":"3016_CR36","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/jama.2016.1346","volume":"315","author":"B Spellberg","year":"2016","unstructured":"Spellberg B, Srinivasan A, Chambers HF (2016) New societal approaches to empowering antibiotic stewardship. JAMA 315(12):1229\u20131230","journal-title":"JAMA"},{"issue":"6","key":"3016_CR37","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nm.3595","volume":"20","author":"SM Strittmatter","year":"2014","unstructured":"Strittmatter SM (2014) Overcoming drug development bottlenecks with repurposing: old drugs learn new tricks. Nat Med 20(6):590\u2013591","journal-title":"Nat Med"},{"issue":"1","key":"3016_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/s-0034-1398742","volume":"36","author":"G Vazquez-Grande","year":"2015","unstructured":"Vazquez-Grande G, Kumar A (2015) Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy. Semin Respir Crit Care Med 36(1):154\u2013166","journal-title":"Semin Respir Crit Care Med"},{"key":"3016_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/minf.200900069","volume":"29","author":"I Vogt","year":"2010","unstructured":"Vogt I, Mestres J (2010) Drug-Target Networks. Mol Inform 29:10\u201314","journal-title":"Mol Inform"},{"issue":"2","key":"3016_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1473-3099(12)70317-1","volume":"13","author":"EMH Wellington","year":"2013","unstructured":"Wellington EMH, Boxall ABA, Cross P (2013) The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria. Lancet Infect Dis 13(2):155\u2013165","journal-title":"Lancet Infect Dis"},{"key":"3016_CR41","unstructured":"World Health Organization (2015) Global action plan on antimicrobial resistance. World Health Organization, Geneva. https:\/\/www.who.int\/antimicrobial-resistance\/global-action-plan\/en\/"},{"key":"3016_CR42","unstructured":"World Health Organization (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization, Geneva. https:\/\/www.who.int\/medicines\/publications\/global-priority-list-antibiotic-resistant-bacteria\/en\/"},{"issue":"10","key":"3016_CR43","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.7150\/ijbs.24612","volume":"14","author":"H Xue","year":"2018","unstructured":"Xue H, Li J, Xie H, Wang Y (2018) Review of drug repositioning approaches and resources. Int J Biol Sci 14(10):1232\u20131244","journal-title":"Int J Biol Sci"},{"key":"3016_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.fitote.2013.10.010","volume":"92","author":"Y Yang","year":"2014","unstructured":"Yang Y, Zhang Z, Li S, Ye X, Li X, He K (2014) Synergy effects of herb extracts: pharmacokinetics and pharmacodynamic basis. Fitoterapia 92:133\u2013147","journal-title":"Fitoterapia"},{"issue":"7","key":"3016_CR45","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1039\/C5MB00306G","volume":"11","author":"Y Yeu","year":"2015","unstructured":"Yeu Y, Yoon Y, Park S (2015) Protein localization vector propagation: a method for improving accuracy of drug repositioning. Mol Biosyst 11(7):2096\u20132102","journal-title":"Mol Biosyst"},{"issue":"2","key":"3016_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/bph.13895","volume":"175","author":"W Zheng","year":"2018","unstructured":"Zheng W, Sun W, Simeonov A (2018) Drug repurposing screens and synergistic drug-combinations for infectious diseases. Br J Pharmacol 175(2):181\u2013191","journal-title":"Br J Pharmacol"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-021-03016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11274-021-03016-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-021-03016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T07:07:29Z","timestamp":1671347249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11274-021-03016-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3016"],"URL":"https:\/\/doi.org\/10.1007\/s11274-021-03016-3","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"7 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no confict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"53"}}